NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 29, 2021 at 05:14 am EDT
Share
NanHua Bio-medicine Co. Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 102.63 million compared to CNY 104.66 million a year ago. Revenue was CNY 102.63 million compared to CNY 104.66 million a year ago. Net loss was CNY 8.4 million compared to CNY 3.5 million a year ago. Basic loss per share from continuing operations was CNY 0.027 compared to CNY 0.0112 a year ago. Diluted loss per share from continuing operations was CNY 0.027 compared to CNY 0.0112 a year ago.
Landfar Bio medicine Co Ltd is a China-based company mainly engaged in the biomedical and energy conservation & environmental protection business. The Companyâs biomedical business includes stem cell storage and technical services, stem cell treatment research, medical instrument purchasing & sales. The Companyâs energy conservation & environmental protection business includes energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The Company is involved in other businesses related to aid and build project. The Company mainly conducts businesses within the domestic market.